Please login to the form below

Off label use

This page shows the latest Off label use news and features for those working in and with pharma, biotech and healthcare.

EU’s 10-year paediatric meds report - not bad, but can do better

label use of adult medicines in children, says the European Commission. ... These include “off-label use of products designed for adults, un-adapted rewards for innovation, and the lack of use of the Orphan Drugs Regulation for paediatric indications”

Latest news

Are rare disease companies naturally more patient-centric?

The starting point for this development pathway is usually off label use, where doctors have been confronted with a difficult patient with very little hope of a true diagnosis or suitable
Promoting off-label use: where to draw the line?

to ensure the safe, effective and targeted off-label use', putting forward eight steps for decision-makers to follow. ... It seems inappropriate under EU law for public authorities to encourage the widespread off-label use of medicines.
Novartis' AMD drug pegpleranib fails phase III programme

s Eylea (aflibercept) and off-label use of Roche's Avastin (bevacizumab).
Up in smoke

of off-label use of hundreds of molecules that have been supposedly 'studied extensively'. ... The very nature of off-label use suggests that there is a lack of evidence and the care with which clinicians use drugs off-label knowing that they haven't
BMS closer to kidney cancer approval for Opdivo

that a sizeable hunk of the turnover for Merck's drug is coming from off-label use in RCC.

More from news
Approximately 1 fully matching, plus 63 partially matching documents found.

Latest Intelligence

Healthcare systems

Healthcare terms - Healthcare systems.
The gold standard of scientific evidence

More than one in five prescriptions in the United States are for an off-label use; providing additional evidence to better understand treatment efficacy and safety is crucial. ... A path forward. Real-world evidence is already in use around the world.
Does safety sell medicines?

New legislation in Europe introduced in 2012 has also led companies to expand what they collect from just side effects to reports of occupational exposure, off-label use and medication errors. ... Through the collection and review of adverse event
Pharma deals during February 2013

Merck &Co has also returned to the biosimilar race following its exit from the Enbrel development programme after Amgen settled an off-label use case for Aranesp in December 2012. ... Between them they will use crowd sourcing to generate novel ideas on
Changes to pharmacovigilance legislation in Europe

of the marketing authorisation (off-label use), as well as the misuse and abuse of the medicinal product. ... More generally, the competent authority may lay down 'any other conditions or restrictions with regard to the safe and effective use of the

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

"Legal highs" ruling leaves illegal labs laughing

This could explain the popularity of Bake Off and the reason so many Brits seem addicted to cake. ... There is a huge amount of off-label use of licensed medicines by medically qualified prescribers.
"Legal highs" ruling leaves illegal labs laughing

This could explain the popularity of Bake Off and the reason so many Brits seem addicted to cake. ... There is a huge amount of off-label use of licensed medicines by medically qualified prescribers.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Senior Medical Writer: Salary is DOE

Healthcare PR Senior Account Manager: Salary TBC

Systematic Review Lead- London: Negotiable

Account Director, Healthcare Advertising Agency: Salary TBC

Senior Account Manager – Healthcare Advertising: Salary TBC

Account Manager, Healthcare Advertising: £30 - 38, 000 (or -)

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Account Director or Senior Account Director: Salary TBC

Integrated Brand/ Digital Senior Account Director, London: Excellent package

Digital Account Director – Health/ Pharma – Global Agency: Salary TBC

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Graduate Scientific Editor: DOE

Healthcare PR Director: £100, 000 – £120, 000 benefits

Account Manager- 4 days per week or full-time: Salary TBC

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Senior Writer, Healthcare Advertising, London: Excellent package

Account Manager: Negotiable

Senior Training Manager - Surrey: Competitive Salary &Bonus

Associate Scientific Director: Salary TBC

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Deputy Managing Director – Healthcare PR – Global Agency: Negotiable

Senior Strategist/ Planner, Healthcare Marketing, London: Excellent package

Medical Writer - Creative and Scientific Projects: DOE

Subscribe to our email news alerts

PMHub

Add my company

PharmiWeb Solutions

PharmiWeb Solutions creates, delivers and manages digital solutions for the pharmaceutical and healthcare segment. From digital marketing, to patient education...

Latest intelligence

PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government: GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....